Lorna Ewart

3.8k total citations
64 papers, 1.8k citations indexed

About

Lorna Ewart is a scholar working on Biomedical Engineering, Small Animals and Molecular Biology. According to data from OpenAlex, Lorna Ewart has authored 64 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biomedical Engineering, 13 papers in Small Animals and 11 papers in Molecular Biology. Recurrent topics in Lorna Ewart's work include 3D Printing in Biomedical Research (22 papers), Animal testing and alternatives (12 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Lorna Ewart is often cited by papers focused on 3D Printing in Biomedical Research (22 papers), Animal testing and alternatives (12 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Lorna Ewart collaborates with scholars based in United Kingdom, United States and Sweden. Lorna Ewart's co-authors include Jean‐Pierre Valentin, Duncan Armstrong, Sven Nylander, Claire Summers, James E. Sidaway, J.J.J. van Giezen, Konstantia Kodella, Adrian Roth, Uwe Marx and Will S. Redfern and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Lorna Ewart

61 papers receiving 1.7k citations

Peers

Countries citing papers authored by Lorna Ewart

Since Specialization

Citations

This map shows the geographic impact of Lorna Ewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorna Ewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorna Ewart more than expected).

Fields of papers citing papers by Lorna Ewart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorna Ewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorna Ewart. The network helps show where Lorna Ewart may publish in the future.

Co-authorship network of co-authors of Lorna Ewart

This figure shows the co-authorship network connecting the top 25 collaborators of Lorna Ewart. A scholar is included among the top collaborators of Lorna Ewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorna Ewart. Lorna Ewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perspective: How complex in vitro models are addressing the challenges of predicting drug-induced liver injury 2025 ·SHILAP Revista de lepidopterología ·Katrina A. Taylor, R. Ram, Lorna Ewart, Christopher E. Goldring, Giusy Russomanno, Guruprasad P. Aithal, Tomasz Kostrzewski, Caroline Bauch, (unknown), Stephanie Modi, J. Gerry Kenna, Jarrod Bailey	0
2	From animal testing to in vitro systems: advancing standardization in microphysiological systems 2024 ·Lab on a Chip ·Darwin R. Reyes, Mandy B. Esch, Lorna Ewart, Rohollah Nasiri, Anna Herland, Kyung E. Sung, (unknown), Carolina Lucchesi, James T. Shoemaker, Jelena Vukasinovic, (unknown), James J. Hickman, Kapil Pant, Anne Marion Taylor, (unknown), Nureddin Ashammakhi	29
3	Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting 2024 ·The Journal of Experimental Medicine ·(unknown), Delphine Planas, Isabelle Staropoli, (unknown), (unknown), (unknown), (unknown), Bárbara F. Fonseca, Rémy Robinot, Stacy Gellenoncourt, Olivier Schwartz, Lorna Ewart, Michael Bscheider, Samy Gobaa, Lisa A. Chakrabarti	10
4	Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety 2024 ·Expert Opinion on Drug Metabolism & Toxicology ·(unknown), Lorna Ewart	6
5	Optimal experimental design for efficient toxicity testing in microphysiological systems: A bone marrow application 2023 ·Frontiers in Pharmacology ·Jonathan Cairns, (unknown), Kainat Khan, (unknown), Gareth Maglennon, (unknown), Stanley E. Lazic, Lorna Ewart, Rhiannon David	8
6	Integrating Liver-Chip data into pharmaceutical decision-making processes 2023 ·Expert Opinion on Drug Discovery ·Daniel Levner, Lorna Ewart	11
7	Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality 2022 ·Journal of Visualized Experiments ·Gauri Kulkarni, Αθανασία Αποστόλου, Lorna Ewart, Carolina Lucchesi, Magdalena Kasendra	7
8	A microengineered Brain-Chip to model neuroinflammation in humans 2022 ·iScience ·Iosif Pediaditakis, Konstantia Kodella, Dimitris V. Manatakis, (unknown), (unknown), Alexander G. Sorets, Achille Gravanis, Lorna Ewart, Lee E. Rubin, Ηλίας Σ. Μανωλάκος, Christopher D. Hinojosa, Katia Karalis	49
9	Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system 2021 ·Communications Biology ·Tomasz Kostrzewski, (unknown), (unknown), S Peel, Zahida Ahmad, (unknown), (unknown), Aurélie Bornot, Julia Lindgren, Maria Ryaboshapkina, Maryam Clausen, Daniel Lindén, Christian Maaß, (unknown), Adam Corrigan, Lorna Ewart, David Hughes	33
10	Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption 2021 ·Nature Communications ·Iosif Pediaditakis, Konstantia Kodella, Dimitris V. Manatakis, (unknown), Chris Hinojosa, William Tien-Street, Ηλίας Σ. Μανωλάκος, Kostas Vekrellis, Geraldine A. Hamilton, Lorna Ewart, Lee L. Rubin, Katia Karalis	150
11	Introducing an automated high content confocal imaging approach for Organs-on-Chips 2019 ·Lab on a Chip ·S Peel, Adam Corrigan, Beate Ehrhardt, Kyung‐Jin Jang, Pedro Caetano-Pinto, (unknown), Jonathan E. Rubins, Konstantia Kodella, Debora B. Petropolis, Janey Ronxhi, Gauri Kulkarni, Alison J. Foster, Dominic P. Williams, Geraldine A. Hamilton, Lorna Ewart	73
12	Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid 2019 ·Archives of Toxicology ·Alison J. Foster, (unknown), Sophie Regan, (unknown), (unknown), Linda C. Andersson, Abhishek Srivastava, Malin Darnell, Jonathan Cairns, Stanley E. Lazic, Kyung‐Jin Jang, Debora B. Petropolis, Konstantia Kodella, Jonathan E. Rubins, Dominic P. Williams, Geraldine A. Hamilton, Lorna Ewart, Paul Morgan	85
13	On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships 2019 ·Scientific Reports ·Christopher W. McAleer, Amy Pointon, Christopher J. Long, (unknown), (unknown), Lee Bridges, (unknown), Kristin Fabre, Robin McDougall, Victorine Muse, Jerome T. Mettetal, Abhishek Srivastava, Dominic P. Williams, Mark T. Schnepper, (unknown), Michael L. Shuler, James J. Hickman, Lorna Ewart	71
14	Advancing nonclinical innovation and safety in pharmaceutical testing 2018 ·Drug Discovery Today ·Elizabeth Baker, (unknown), Ellen L. Berg, (unknown), P. Charukeshi Chandrasekera, J. Lowry Curley, Bruce A. Donzanti, Lorna Ewart, (unknown), J. Gerry Kenna, Edward L. LeCluyse, Michael Liebman, (unknown), Paul B. Watkins, Kristie Sullivan	8
15	Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting 2018 ·Advanced Drug Delivery Reviews ·Kristin Fabre, Louise Delsing, Ryan Hicks, Nicola Colclough, Damian C. Crowther, Lorna Ewart	19
16	The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative 2014 ·Toxicological Sciences ·Lorna Ewart, Mike Aylott, Mark Deurinck, (unknown), David J. Gallacher, Helena Geys, Philip Jarvis, Haisong Ju, Derek J. Leishman, (unknown), Nick McMahon, Andy Mead, Philip H. Milliken, Willi Suter, Ard Teisman, Karel Van Ammel, Hugo M. Vargas, Rob Wallis, Jean‐Pierre Valentin	53
17	An evaluation of the non-invasive faecal pellet assessment method as an early drug discovery screen for gastrointestinal liability 2013 ·Journal of Pharmacological and Toxicological Methods ·(unknown), (unknown), (unknown), Nick Moore, (unknown), Jean‐Pierre Valentin, Lorna Ewart	11
18	Translational pharmacokinetic–pharmacodynamic modeling of QTc effects in dog and human 2013 ·Journal of Pharmacological and Toxicological Methods ·Joanna Parkinson, Sandra A. G. Visser, Philip Jarvis, Chris Pollard, Jean‐Pierre Valentin, James Yates, Lorna Ewart	35
19	The role of the anaesthetised guinea-pig in the preclinical cardiac safety evaluation of drug candidate compounds 2012 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), (unknown), Lorna Ewart, Pierre Lainée, Matthew Skinner, Sarah Kirk, Jean‐Pierre Valentin	23
20	The validation of an in vitro colonic motility assay as a biomarker for gastrointestinal adverse drug reactions 2010 ·Toxicology and Applied Pharmacology ·Christopher Keating, Vicente Martı́nez, Lorna Ewart, (unknown), Luke Grundy, Jean‐Pierre Valentin, David Grundy	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact